Cargando…

Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models

PURPOSE: ALK-activating mutations are identified in approximately 10% of newly diagnosed neuroblastomas and ALK amplifications in a further 1%–2% of cases. Lorlatinib, a third-generation anaplastic lymphoma kinase (ALK) inhibitor, will soon be given alongside induction chemotherapy for children with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tucker, Elizabeth R., Jiménez, Irene, Chen, Lindi, Bellini, Angela, Gorrini, Chiara, Calton, Elizabeth, Gao, Qiong, Che, Harvey, Poon, Evon, Jamin, Yann, Martins Da Costa, Barbara, Barker, Karen, Shrestha, Sumana, Hutchinson, J. Ciaran, Dhariwal, Simran, Goodman, Angharad, Del Nery, Elaine, Gestraud, Pierre, Bhalshankar, Jaydutt, Iddir, Yasmine, Saberi-Ansari, Elnaz, Saint-Charles, Alexandra, Geoerger, Birgit, Marques Da Costa, Maria Eugénia, Pierre-Eugène, Cécile, Janoueix-Lerosey, Isabelle, Decaudin, Didier, Nemati, Fariba, Carcaboso, Angel M., Surdez, Didier, Delattre, Olivier, George, Sally L., Chesler, Louis, Tweddle, Deborah A., Schleiermacher, Gudrun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for Cancer Research 2023
Materias:	Translational Cancer Mechanisms and Therapy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068437/ https://www.ncbi.nlm.nih.gov/pubmed/36602782 http://dx.doi.org/10.1158/1078-0432.CCR-22-2274

Ejemplares similares

Reversible transitions between noradrenergic and mesenchymal tumor identities define cell plasticity in neuroblastoma
por: Thirant, Cécile, et al.
Publicado: (2023)

Control-FREEC: a tool for assessing copy number and allelic content using next-generation sequencing data
por: Boeva, Valentina, et al.
Publicado: (2012)

Single-cell transcriptomics reveals shared immunosuppressive landscapes of mouse and human neuroblastoma
por: Costa, Ana, et al.
Publicado: (2022)

Activated ALK signals through the ERK–ETV5–RET pathway to drive neuroblastoma oncogenesis
por: Lopez-Delisle, Lucille, et al.
Publicado: (2018)

Learning smoothing models of copy number profiles using breakpoint annotations
por: Hocking, Toby Dylan, et al.
Publicado: (2013)

High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma
por: Louis-Brennetot, Caroline, et al.
Publicado: (2020)

Plasticity in Neuroblastoma Cell Identity Defines a Noradrenergic-to-Mesenchymal Transition (NMT)
por: Gautier, Margot, et al.
Publicado: (2021)

Identification of different ALK mutations in a pair of neuroblastoma cell lines established at diagnosis and relapse
por: Chen, Lindi, et al.
Publicado: (2016)

SegAnnDB: interactive Web-based genomic segmentation
por: Hocking, Toby D., et al.
Publicado: (2014)

ALK mutation dynamics and clonal evolution in a neuroblastoma model exhibiting two ALK mutations
por: Durand, Simon, et al.
Publicado: (2019)

Study of chromatin remodeling genes implicates SMARCA4 as a putative player in oncogenesis in neuroblastoma
por: Bellini, Angela, et al.
Publicado: (2019)

Cell-Free DNA Extracted from CSF for the Molecular Diagnosis of Pediatric Embryonal Brain Tumors
por: Chicard, Mathieu, et al.
Publicado: (2023)

Control-free calling of copy number alterations in deep-sequencing data using GC-content normalization
por: Boeva, Valentina, et al.
Publicado: (2011)

The occurrence of intracranial rhabdoid tumours in mice depends on temporal control of Smarcb1 inactivation
por: Han, Zhi-Yan, et al.
Publicado: (2016)

Breakpoint Features of Genomic Rearrangements in Neuroblastoma with Unbalanced Translocations and Chromothripsis
por: Boeva, Valentina, et al.
Publicado: (2013)

SVDetect: a tool to identify genomic structural variations from paired-end and mate-pair sequencing data
por: Zeitouni, Bruno, et al.
Publicado: (2010)

Activated Alk triggers prolonged neurogenesis and Ret upregulation providing a therapeutic target in ALK-mutated neuroblastoma
por: Cazes, Alex, et al.
Publicado: (2014)

Targeting MYCN and ALK in resistant and relapsing neuroblastoma
por: Tucker, Elizabeth R, et al.
Publicado: (2019)

Radiogenomics of neuroblastomas: Relationships between imaging phenotypes, tumor genomic profile and survival
por: Brisse, Hervé J., et al.
Publicado: (2017)

Localizing potentially active post-transcriptional regulations in the Ewing's sarcoma gene regulatory network
por: Baumuratova, Tatiana, et al.
Publicado: (2010)

Systems biology of Ewing sarcoma: a network model of EWS-FLI1 effect on proliferation and apoptosis
por: Stoll, Gautier, et al.
Publicado: (2013)

p53, SKP2, and DKK3 as MYCN Target Genes and Their Potential Therapeutic Significance
por: Chen, Lindi, et al.
Publicado: (2012)

BET and CDK Inhibition Reveal Differences in the Proliferation Control of Sympathetic Ganglion Neuroblasts and Adrenal Chromaffin Cells
por: Sriha, Jessica, et al.
Publicado: (2022)

End-Cycle Sow Carcass Condemnation in a French Slaughterhouse
por: Decaudin, Pierre-Yves, et al.
Publicado: (2017)

De novo motif identification improves the accuracy of predicting transcription factor binding sites in ChIP-Seq data analysis
por: Boeva, Valentina, et al.
Publicado: (2010)

A Probabilistic Model for Cell Population Phenotyping Using HCS Data
por: Pauwels, Edouard, et al.
Publicado: (2012)

Internalization and Down-Regulation of the ALK Receptor in Neuroblastoma Cell Lines upon Monoclonal Antibodies Treatment
por: Mazot, Pierre, et al.
Publicado: (2012)

Clinical Characteristics and Outcome of Patients with Neuroblastoma Presenting Genomic Amplification of Loci Other than MYCN
por: Guimier, Anne, et al.
Publicado: (2014)

QuantumClone: clonal assessment of functional mutations in cancer based on a genotype-aware method for clonal reconstruction
por: Deveau, Paul, et al.
Publicado: (2018)

Molecular profiling of patient-derived breast cancer xenografts
por: Reyal, Fabien, et al.
Publicado: (2012)

SV-Bay: structural variant detection in cancer genomes using a Bayesian approach with correction for GC-content and read mappability
por: Iakovishina, Daria, et al.
Publicado: (2016)

Biological Role of MYCN in Medulloblastoma: Novel Therapeutic Opportunities and Challenges Ahead
por: Shrestha, Sumana, et al.
Publicado: (2021)

Polarity gene alterations in pure invasive micropapillary carcinomas of the breast
por: Gruel, Nadège, et al.
Publicado: (2014)

HMCan-diff: a method to detect changes in histone modifications in cells with different genetic characteristics
por: Ashoor, Haitham, et al.
Publicado: (2017)

Combinations of targeted therapies in human cancers
por: Decaudin, Didier, et al.
Publicado: (2016)

Wild-type ALK and activating ALK-R1275Q and ALK-F1174L mutations upregulate Myc and initiate tumor formation in murine neural crest progenitor cells
por: Montavon, Gisèle, et al.
Publicado: (2014)

A biobank of pediatric patient-derived-xenograft models in cancer precision medicine trial MAPPYACTS for relapsed and refractory tumors
por: Marques Da Costa, Maria Eugénia, et al.
Publicado: (2023)

ATR Inhibition Potentiates PARP Inhibitor Cytotoxicity in High Risk Neuroblastoma Cell Lines by Multiple Mechanisms
por: Southgate, Harriet E. D., et al.
Publicado: (2020)

Targeting the DNA Damage Response for the Treatment of High Risk Neuroblastoma
por: Southgate, Harriet E. D., et al.
Publicado: (2020)

Hyperactivation of Alk induces neonatal lethality in knock-in Alk(F1178L) mice
por: Lopez-Delisle, Lucille, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_obcu25pe0anme6ql5f6saan9cb